You are here: Home » Current Affairs » Coronavirus » News
Business Standard

China plans to offer experimental Covid vaccine to students going abroad

The two shots being developed by CNBG -- which are still in the final, third phase of testing -- were authorised for emergency use in China

Topics
China | Coronavirus Vaccine | Coronavirus

Bloomberg 

Coronavirus, vaccine, covid
CNBG appears to be trying to gauge interest among the general public for its vaccine candidates

One of China’s leading vaccine developers is working on a plan to inoculate students going overseas with Covid-19 shots that are yet to get regulatory approval, according to people familiar with the matter, as the country pushes scientific boundaries in the race for a viable immunisation.

National Biotec Group Co., or CNBG, a subsidiary of state-owned Sinopharm Group Co, is in talks with the Chinese government about giving students headed abroad to study its experimental vaccines, said the people, who asked not to be identified as they’re not authorised to speak publicly. Various government agencies are still working on the plan and no final decision has been made, the people said.

The two shots being developed by CNBG -- which are still in the final, third phase of testing -- were authorised for emergency use in and have already been administered to hundreds of thousands of people there, including medical workers and employees of state-owned companies working in high-risk countries. Students would represent an unprecedented expansion in the use of vaccines which haven’t completed full human testing, though the Chinese regulator can determine that the group can come under the remit of emergency use.

“This would indeed be expanding the granted emergency use permit to beyond their intent,” said Nigel McMillan, director of the infectious diseases and immunology program at Griffith University’s Menzies Health Institute Queensland. “While obviously very important to the families and students involved, studying abroad is not an emergency – no lives are at threat here.”

CNBG did not respond to multiple calls and text messages seeking comment, and China’s Ministry of Education also didn’t respond to phone calls.

Vaccine Interest

Student concern about leaving China, where the pathogen has been nearly eradicated through aggressive containment measures, for foreign countries where the is still spreading rapidly prompted the discussions, the people said. Infections in the US and Europe are re-surging, while outbreaks across South America and India show few signs of coming under control.

CNBG appears to be trying to gauge interest among the general public for its vaccine candidates, with a link on its website allowing people to apply to receive a shot. It asked for personal details and what city they wanted to receive the injection. More than 154,000 people as of Tuesday morning in had registered, and a notice at the end of the registration form said that students going overseas could receive the vaccines for free. Later in the day, the weblink seemed to stop working.

The registration exercise is for planning purposes and no actual vaccines have been administered yet to anyone who’s signed up, said the people.

Fast Track

Chinese vaccine developers have been at the forefront of the global race to create an effective immunisation against the virus, which has taken on vital importance as countries look to move beyond Covid-19 and fully re-open their economies. Vaccine development processes that usually take years have been compressed into months in many places, encouraged by politicians wanting a quick fix to the pandemic.

Western frontrunners like Johnson & Johnson and AstraZeneca Plc have temporarily halted their trials in recent months after unexplained illnesses in participants. Sinopharm said in September that it’s observed no adverse reactions in trial subjects that have received its vaccines, which are in final-stage testing in the Middle East and South America.

At a briefing last month, Zheng Zhongwei, an official at China’s National Health Commission, said no serious adverse reactions have been recorded in vaccines used in the emergency use program.

The Drugs and Vaccines That Might End the Pandemic

Chinese media reported Tuesday that students -- among other groups -- were allowed to book appointments for CNBG vaccinations in the cities of Beijing and Wuhan.

Griffith’s McMillan said that dosing non-trial subjects while testing is still ongoing carries risks. “I would suggest this is not only unjustified but unsafe as well,” he said.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, October 13 2020. 18:45 IST
RECOMMENDED FOR YOU